Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH)

6.98
Delayed Data
As of Sep 19
 -0.13 / -1.83%
Today’s Change
3.11
Today|||52-Week Range
9.93
+73.20%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues10.5M9.1M11.7M5.1M
 
 
 
 
 
Depreciation And Amortization129.0K124.0K193.0K282.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses38.5M74.7M94.5M82.7M
 
 
 
 
 
Research And Development31.5M61.9M73.8M63.8M
 
 
 
 
 
Total Operating Expenses38.7M74.9M94.7M83.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-28.2M-65.8M-83.0M-77.8M
 
 
 
 
 
Interest Expense On Debt1.7M1.0M231.0K--
 
 
 
 
Other Expenses263.0K24.0K-2.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-29.6M-66.7M-83.2M-77.5M
 
 
 
 
 
Net Income-29.6M-66.7M-83.2M-77.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS16.7M26.8M35.3M36.7M
 
 
 
 
 
Shares To Calculate EPS Diluted16.7M26.8M35.3M36.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.78-$2.49-$2.36-$2.11
 
 
 
 
 
EPS Diluted-$1.78-$2.49-$2.36-$2.11